AzTrials
AzTrials

Imposter SyndromeNCT07019974

Imposter Syndrome in Medical Students and Its Relation With Stress

An observational study of Imposter Syndrome and Medical Students, run by Rawalpindi Medical College at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this observational study is to examine the relationship between Imposter Syndrome and stress in undergraduate medical students at Rawalpindi Medical University, with particular attention to variables such as gender, academic year, and academic performance. Read more about this study

Who is it for?
Ages 18 to 29 yearsHealthy volunteers can take part
Conditions the study is for
Imposter Syndrome, Medical Students
How many people
6 participants
Where
1 sitePakistan
Study dates
17 May 2024to 20 Aug 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 29 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Undergraduate MBBS students enrolled at Rawalpindi Medical University

Who may be able to join

  • Undergraduate MBBS students enrolled at Rawalpindi Medical University
  • Students from any year of study (1st to final year)
  • Willingness to participate, demonstrated by providing informed consent
  • Ability to complete the online questionnaire independently

Who cannot join

  • Postgraduate medical students or students from other disciplines (e.g., nursing, dentistry)
  • Participants with known psychiatric diagnoses (e.g., depression, anxiety disorders) that could confound stress or Imposter Syndrome assessments
  • Incomplete or partially filled questionnaires
  • Students who did not consent to participate in the study

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • Rawalpindi Medical University

    Rawalpindi, Punjab Province

Other trials in Pakistan

About this study

Official title: Imposter Syndrome In Medical Students And Its Relationship With Stress

The goal of this observational study is to examine the relationship between Imposter Syndrome and stress in undergraduate medical students at Rawalpindi Medical University, with particular attention to variables such as gender, academic year, and academic performance.

The main questions it aims to answer are:

Read more

Is there a positive correlation between Imposter Syndrome and stress?

Are gender and year of study associated with differences in stress and Imposter Syndrome levels?

Participants will:

Complete an online questionnaire including demographic questions

Fill out the Clance Impostor Phenomenon Scale (CIPS) to assess Imposter Syndrome

Complete the Perceived Stress Scale (PSS) to measure stress levels

Medical subject headings
imposter syndrome

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Level of Imposter Syndrome among undergraduate medical students

    The degree of Imposter Syndrome will be measured using the Clance Impostor Phenomenon Scale (CIPS). Participants will receive a total score based on their responses, which will be categorized as few characteristics, moderate, frequent, or intense. The outcome will help identify the prevalence and severity of Imposter Syndrome in the study population and will be analyzed in relation to stress, gender, and academic year.

    Measured: May - August 2024

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2025
  2. Study start17 May 2024
  3. Primary completion20 Aug 2024
  4. Study completion20 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Ecologic or community
Time perspective
Cross-sectional
Enrolment
6 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07019974
Sponsor's protocol ID
PH46 46 24
Status last verified
Jun 2025
First submitted
5 Jun 2025
Last updated
13 Jun 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Imposter Syndrome and Medical Students, run by Rawalpindi Medical College at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Level of Imposter Syndrome among undergraduate medical students (time frame: May - August 2024). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in